세계의 대장 수술 시장 규모, 점유율, 동향 분석 : 제품별, 수술 유형별, 적응증별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Colorectal Surgery Market Size, Share & Trends Analysis Report By Product (Endoscopes, Electrosurgical Devices), By Surgery Type (Right Hemicolectomy, Left Hemicolectomy), By Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

대장 수술 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 대장 수술 시장 규모는 2025-2030년에 8.64%의 CAGR을 기록하며, 2030년에는 366억 6,000만 달러에 달할 것으로 추정되고 있습니다.

대장암, 염증성장질환(IBD), 게실염을 포함한 대장질환의 유병률 증가가 주요 촉진요인입니다. 대장암은 전 세계에서 가장 흔한 암 중 하나이며, 세계보건기구(WHO)는 2020년에 190만 명 이상의 신규 환자와 100만 명에 가까운 사망자가 발생할 것으로 보고하고 있습니다. 이러한 높은 발병률은 외과적 개입에 대한 큰 수요를 창출하고 있습니다.

기술 발전도 중요한 역할을 하고 있습니다. 복강경 수술 및 로봇 보조 수술과 같은 최소침습 수술 기법의 혁신은 정확도와 환자 결과를 개선하고 회복 시간과 합병증을 감소시키고 있습니다. 고해상도 및 4K 내시경과 같은 첨단 영상 기술의 통합은 진단 정확도를 높이고 이러한 기술의 채택을 더욱 촉진하고 있습니다.

규제 당국의 지원과 정부 구상도 중요한 성장 촉진요인입니다. 예를 들어 미국 예방 서비스 전문위원회(USPSTF)는 최근 대장암 검진 권장 연령을 45세로 낮추어 진단 및 수술에 대한 수요를 증가시켰습니다. 유럽 각국에서도 대장암의 조기 발견과 조기 치료를 장려하는 국가 검진 프로그램을 시행하고 있으며, 시장 확대에 힘을 실어주고 있습니다. 올림푸스의 EVIS X1과 같은 AI 지원 내시경 시스템 출시와 같은 최근 동향도 시장 개발에 힘을 실어주고 있습니다. 이러한 기술 혁신은 실시간 데이터와 향상된 시각화를 제공하여 대장질환을 조기에 발견하고 치료하는 데 도움을 주고 있습니다.

대장 수술 시장 : 분석 개요

• 제품별로는 내시경이 중요한 역할을 하는 최소침습 수술의 채택이 증가함에 따라 내시경 부문이 2024년 31.6%의 높은 점유율로 시장을 독점했습니다.
• 수술 유형별로는 아전반절제술이 2024년 28%로 가장 큰 매출 점유율을 차지했습니다.
• 적응증별로는 대장암 부문이 2024년 시장을 독점했습니다. 이는 주로 대장암의 높은 유병률, 조기 발견 및 치료의 발전, 연구개발에 대한 막대한 투자에 기인합니다.

목차

제1장 분석 방법·범위

제2장 개요

제3장 대장 수술 시장 : 변동 요인·동향·범위

• 시장 연관 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회
  • 시장이 해결해야 할 과제
• 대장 수술 시장 : 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 대장 수술 시장 : 제품별 추정·동향 분석

• 세계의 대장 수술 시장 : 대시보드, 제품별
• 세계의 대장 수술 시장 : 변동 분석, 제품별
• 세계의 대장 수술 시장 : 제품별(매출 기반)
• 내시경
• 전기외과 기기
• 시각 시스템·핸드헬드 기기
• 실링·스테이플 기기
• 결찰 클립·확장기
• 절단 기구(커터·가위)
• 수술용 액세서리

제5장 대장 수술 시장 : 수술 유형별 추정·동향 분석

• 세계의 대장 수술 시장 : 대시보드, 수술 유형별
• 세계의 대장 수술 시장 : 변동 분석, 수술 유형별
• 수술 유형별(매출 기반)
• 우반 결장 절제술
• 좌반 결장 절제술
• 아전반 결장 절제술
• 저위 전방 절제
• 복회음 절제술
• 기타

제6장 대장 수술 시장 : 적응증별 추정·동향 분석

• 세계의 대장 수술 시장 : 대시보드, 적응증별
• 세계의 대장 수술 시장 : 변동 분석, 적응증별
• 적응증별(매출 기반)
• 대장 폴립
• 크론병
• 대장암
• 대장염
• 과민성대장증후군(IBS)
• 기타

제7장 대장 수술 시장 : 최종 용도별 추정·동향 분석

• 세계의 대장 수술 시장 : 대시보드, 최종 용도별
• 세계의 대장 수술 시장 : 변동 분석, 최종 용도별
• 최종 용도별(매출 기반)
• 병원·클리닉
• 외과 센터
• 기타

제8장 대장 수술 시장 : 지역 추정·동향 분석(제품별·수술 유형별·적응증별·최종 용도별)

• 지역 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 기업/경쟁 분류
• 벤더 구도
  • 주요 판매 대리점 및 채널 파트너 리스트
  • 주요 기업의 시장 점유율 분석(2024년)
  • Intuitive Surgical
  • Medtronic plc
  • Johnson &Johnson
  • Stryker Corporation
  • Olympus Corporation
  • Conmed Corporation
  • B. Braun SE
  • Karl Storz SE &Co. KG
  • Boston Scientific Corporation

KSA

영문 목차

영문목차

Colorectal Surgery Market Growth & Trends:

The global colorectal surgery market size is estimated to reach USD 36.66 billion by 2030, registering a CAGR of 8.64% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of colorectal diseases, including colorectal cancer, inflammatory bowel disease (IBD), and diverticulitis, is a major driver. Colorectal cancer is one of the most common cancers globally, with the World Health Organization (WHO) reporting over 1.9 million new cases and nearly 1 million deaths in 2020. This high incidence creates a substantial demand for surgical interventions.

Technological advancements also play a crucial role. Innovations in minimally invasive surgical techniques, such as laparoscopic and robotic-assisted surgeries, have improved precision and patient outcomes, reducing recovery times and complications. The integration of advanced imaging technologies, like high-definition and 4K endoscopy, enhances diagnostic accuracy, further driving the adoption of these technologies.

Regulatory support and government initiatives are significant growth drivers as well. For example, the U.S. Preventive Services Task Force (USPSTF) recently lowered the recommended screening age for colorectal cancer to 45, increasing the demand for diagnostic and surgical procedures. Similarly, various European countries have implemented national screening programs that encourage early detection and treatment of colorectal cancer, supporting market expansion. Recent developments, such as the launch of AI-assisted endoscopy systems like Olympus' EVIS X1, are also enhancing market growth. These innovations offer real-time data and improved visualization, aiding in the early detection and treatment of colorectal conditions.

Colorectal Surgery Market Report Highlights:

• Based on product, the endoscopes segment dominated the market with a substantial share of 31.6% in 2024, driven by the increasing adoption of minimally invasive procedures, where endoscopes play a crucial role.
• Based on surgery type, the subtotal hemicolectomy segment held the largest revenue share of 28% in 2024.
• Based on indication, the colorectal cancer segment dominated the market in 2024. This is primarily attributed to the high prevalence of colorectal cancer, advancements in early detection and treatment, and significant investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Surgery type
  • 1.2.3. Indication
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Surgery type
  • 2.2.3. Indication
  • 2.2.4. End Use
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Colorectal Surgery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High prevalence of appendicitis
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing preference for minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High costs of advanced surgery type
    • 3.2.2.2. Risk of complications
  • 3.2.3. Market challenges analysis
  • 3.2.4. Market opportunities analysis
• 3.3. Colorectal Surgery Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Colorectal Surgery Market: Product Estimates & Trend Analysis

• 4.1. Global Colorectal Surgery Market: Product Dashboard
• 4.2. Global Colorectal Surgery Market: Product Movement Analysis
• 4.3. Global Colorectal Surgery Market by Product, Revenue
• 4.4. Endoscopes
  • 4.4.1. Endoscopes market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Electrosurgical Devices
  • 4.5.1. Electrosurgical devices market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Visual Systems & Handheld Instruments
  • 4.6.1. Visual systems & handheld instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Sealing & Stapling Devices
  • 4.7.1. Sealing & stapling devices market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Ligation Clips & Dilators
  • 4.8.1. Ligation clips & dilators market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Cutting Instruments (Cutters & Shears)
  • 4.9.1. Cutting instruments (Cutters & Shears) market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Surgical Accessories
  • 4.10.1. Surgical accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Colorectal Surgery Market: Surgery Type Estimates & Trend Analysis

• 5.1. Global Colorectal Surgery Market: Surgery Type Dashboard
• 5.2. Global Colorectal Surgery Market: Surgery Type Movement Analysis
• 5.3. Global Colorectal Surgery Market Estimates and Forecasts, By Surgery Type, Revenue (USD Million)
• 5.4. Right Hemicolectomy
  • 5.4.1. Right hemicolectomy market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Left Hemicolectomy
  • 5.5.1. Left hemicolectomy market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Subtotal Hemicolectomy
  • 5.6.1. Subtotal hemicolectomy market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Low Anterior Resection
  • 5.7.1. Low anterior resection market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Abdomino-Perineal Resection
  • 5.8.1. Abdomino-Perineal resection market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Colorectal Surgery Market: Indication Estimates & Trend Analysis

• 6.1. Global Colorectal Surgery Market: Indication Dashboard
• 6.2. Global Colorectal Surgery Market: Indication Movement Analysis
• 6.3. Global Colorectal Surgery Market Estimates and Forecasts, By Indication, Revenue (USD Million)
• 6.4. Colon Polyps
  • 6.4.1. Colon polyps market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Crohn's Disease
  • 6.5.1. Crohn's disease market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Colorectal Cancer
  • 6.6.1. Colorectal cancer market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Colitis
  • 6.7.1. Colitis market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Irritable Bowel Syndrome (IBS)
  • 6.8.1. Irritable Bowel Syndrome (IBS) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Colorectal Surgery Market: End Use Estimates & Trend Analysis

• 7.1. Global Colorectal Surgery Market: End Use Dashboard
• 7.2. Global Colorectal Surgery Market: End Use Movement Analysis
• 7.3. Global Colorectal Surgery Market Estimates and Forecasts, By End Use, Revenue (USD Million)
• 7.4. Hospital & Clinics
  • 7.4.1. Hospital market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Surgery Centers
  • 7.5.1. Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Other
  • 7.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Colorectal Surgery Market: Regional Estimates & Trend Analysis by Product, Surgery type, Indication and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key company market share analysis, 2024
  • 9.2.3. Intuitive Surgical
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Medtronic plc
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Johnson & Johnson
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Stryker Corporation
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Olympus Corporation
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Conmed Corporation
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. B. Braun SE
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Karl Storz SE & Co. KG
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Boston Scientific Corporation
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives

관련자료